Drug Type Unknown |
Synonyms SYNT 002, SYNT002 |
Target |
Mechanism CD23 antagonists(Immunoglobulin epsilon Fc receptor antagonists), Immunomodulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metabolic Diseases | Preclinical | US | - |